Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.67 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.86.
Market Cap
9.67T
Revenue
4.66T
Profits
186.46B
PE Ratio
51.86
Profit Margin
4.00%
Dividend Yield
0.37%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.11T | 0.19% | 807,675 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 658.87B | 0.13% | 2,173,277 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 471.06B | 0.77% | 1,219,804 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 386.24B | 3.91% | 6,435,370 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 357.45B | -0.13% | 1,408,771 | 450.53B |
| 6 | NVS | Novartis AG | 300.52B | 1.27% | 582,797 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 263.84B | 1.82% | 1,515,016 | 61.37B |
| 8 | AMGN | Amgen Inc. | 240.77B | 0.34% | 1,167,203 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 231.89B | -0.25% | 816,878 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 212.51B | 2.72% | 9,892,684 | 50.34B |
| 11 | ABT | Abbott Laboratories | 200.48B | -0.69% | 3,046,471 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 184.06B | 1.16% | 2,249,499 | 30.46B |
| 13 | PFE | Pfizer Inc. | 162.33B | 1.82% | 15,327,299 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.34B | 0.08% | 1,081,924 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 140.67B | 1.35% | 290,755 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 138.70B | 0.92% | 2,608,613 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 131.21B | -0.58% | 1,005,169 | 11.03B |
| 18 | SYK | Stryker Corporation | 127.05B | 1.05% | 1,142,364 | 25.84B |
| 19 | CVS | CVS Health Corporation | 119.02B | -1.12% | 1,878,140 | 412.65B |
| 20 | MDT | Medtronic plc | 117.66B | -1.05% | 3,339,878 | 36.36B |
| 21 | SNY | Sanofi | 109.43B | 0.54% | 745,011 | 55.89B |
| 22 | MCK | McKesson Corporation | 104.59B | 2.67% | 357,555 | 410.98B |
| 23 | GSK | GSK plc | 103.35B | 0.56% | 1,577,666 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.74B | -0.20% | 385,832 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.69B | -0.72% | 238,480 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 83.55B | 0.99% | 281,561 | 15.53B |
| 27 | CI | The Cigna Group | 73.49B | -0.84% | 341,559 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 72.19B | 1.63% | 7,892,590 | 21.00B |
| 29 | ARGX | argenx SE | 63.06B | 1.18% | 66,798 | 5.32B |
| 30 | MRNA | Moderna, Inc. | 62.82B | 13.28% | 36,727,056 | 2.23B |
| 31 | COR | Cencora, Inc. | 62.04B | 0.41% | 445,188 | 332.77B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.35B | 0.49% | 818,835 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 54.90B | 1.59% | 600,391 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.23B | 0.13% | 717,048 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.68B | -0.52% | 645,545 | 22.48B |
| 36 | NTRA | Natera, Inc. | 48.07B | 1.76% | 1,171,146 | 2.71B |
| 37 | MDLN | Medline Inc. | 46.63B | 2.22% | 2,430,149 | 29.94B |
| 38 | HUM | Humana Inc. | 46.39B | -0.08% | 439,336 | 145.68B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.04B | -0.69% | 478,634 | - |
| 40 | HLN | Haleon plc | 44.44B | 0.05% | 3,619,569 | 14.80B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 43.89B | 1.98% | 1,818,612 | 17.32B |
| 42 | A | Agilent Technologies, Inc. | 43.75B | 0.97% | 1,095,147 | 7.23B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 43.64B | -0.99% | 166,461 | 4.55B |
| 44 | ONC | BeOne Medicines AG | 43.20B | 2.13% | 166,156 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 42.59B | -0.56% | 373,664 | 16.98B |
| 46 | WAT | Waters Corporation | 40.72B | 0.91% | 203,134 | 4.64B |
| 47 | VEEV | Veeva Systems Inc. | 39.74B | -1.53% | 907,122 | 3.32B |
| 48 | RPRX | Royalty Pharma plc | 35.89B | 1.76% | 839,715 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.53B | -0.53% | 517,923 | 10.86B |
| 50 | RMD | ResMed Inc. | 34.26B | 2.17% | 702,478 | 5.65B |
| 51 | DXCM | DexCom, Inc. | 34.16B | -0.58% | 2,191,023 | 4.97B |
| 52 | ILMN | Illumina, Inc. | 34.16B | 1.34% | 837,845 | 4.49B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 33.59B | 0.23% | 973,935 | 21.27B |
| 54 | BIIB | Biogen Inc. | 32.85B | 1.92% | 243,241 | 10.03B |
| 55 | CNC | Centene Corporation | 32.18B | -0.76% | 2,194,916 | 180.30B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.16B | 1.84% | 656,747 | 4.80B |
| 57 | ZTS | Zoetis Inc. | 31.90B | 0.05% | 1,863,466 | 9.53B |
| 58 | BNTX | BioNTech SE | 28.98B | 2.25% | 806,866 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 27.98B | -0.17% | 42,700 | 4.13B |
| 60 | INSM | Insmed Incorporated | 27.40B | 1.20% | 672,534 | 1.14B |
| 61 | LH | Labcorp Holdings Inc. | 27.12B | -1.44% | 330,036 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 26.93B | -0.40% | 243,643 | 20.18B |
| 63 | DGX | Quest Diagnostics Incorporated | 26.89B | -0.09% | 252,409 | 11.56B |
| 64 | INCY | Incyte Corporation | 26.43B | 1.90% | 610,244 | 5.82B |
| 65 | ROIV | Roivant Sciences Ltd. | 26.32B | 0.22% | 2,203,430 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.72B | -0.58% | 147,197 | 3.33B |
| 67 | STE | STERIS plc | 23.25B | 0.24% | 254,592 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.23B | 1.06% | 129,647 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 22.06B | 0.72% | 696,274 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.96B | -2.10% | 305,677 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.69B | 3.73% | 1,316,272 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.20B | -0.33% | 493,263 | 8.51B |
| 73 | VTRS | Viatris Inc. | 19.12B | 0.67% | 2,728,730 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.00B | -1.78% | 84,457 | 2.78B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 16.86B | 2.06% | 978,718 | 4.60B |
| 76 | ASND | Ascendis Pharma A/S | 16.57B | 0.15% | 140,833 | 1.20B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.76B | -0.54% | 638,502 | 713.07M |
| 78 | SOLV | Solventum Corporation | 15.61B | 0.53% | 435,228 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 15.58B | 0.12% | 494,559 | 3.37B |
| 80 | COO | The Cooper Companies, Inc. | 14.40B | -2.60% | 570,836 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.21B | -0.33% | 298,837 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.93B | 1.46% | 358,720 | 2.91B |
| 83 | EXEL | Exelixis, Inc. | 13.92B | 2.97% | 817,502 | 2.44B |
| 84 | BAX | Baxter International Inc. | 13.64B | -0.40% | 1,731,978 | 11.47B |
| 85 | CORT | Corcept Therapeutics Incorporated | 13.27B | -0.40% | 354,316 | 830.81M |
| 86 | ICLR | ICON Public Limited Company | 13.04B | -2.59% | 202,568 | 8.29B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.81B | 1.73% | 489,439 | 3.41B |
| 88 | PEN | Penumbra, Inc. | 12.78B | 0.24% | 93,857 | 1.50B |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.67B | 3.83% | 1,974,865 | 5.02B |
| 90 | TEM | Tempus AI, Inc. | 12.64B | 5.91% | 6,511,920 | 1.43B |
| 91 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.53B | 2.29% | 413,998 | 669.50M |
| 92 | FMS | Fresenius Medical Care AG | 12.48B | -0.25% | 437,388 | 22.19B |
| 93 | SNN | Smith & Nephew plc | 12.42B | -1.22% | 887,781 | 6.30B |
| 94 | HALO | Halozyme Therapeutics, Inc. | 12.40B | 0.55% | 588,534 | 1.66B |
| 95 | BTSG | BrightSpring Health Services, Inc. | 11.90B | -3.97% | 947,851 | 14.37B |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | 0.59% | 57,619 | 1.28B |
| 97 | EHC | Encompass Health Corporation | 11.80B | -1.08% | 223,184 | 6.21B |
| 98 | ALGN | Align Technology, Inc. | 11.36B | 0.19% | 311,965 | 4.14B |
| 99 | TECH | Bio-Techne Corporation | 11.34B | -0.07% | 1,060,106 | 1.22B |
| 100 | DVA | DaVita Inc. | 11.28B | 0.24% | 221,446 | 14.01B |
| 101 | GMED | Globus Medical, Inc. | 11.27B | -0.15% | 484,531 | 3.14B |
| 102 | ABVX | ABIVAX Société Anonyme | 11.17B | 2.38% | 529,213 | 5.67M |
| 103 | CYTK | Cytokinetics, Incorporated | 10.88B | 1.56% | 498,044 | 67.67M |
| 104 | GKOS | Glaukos Corporation | 10.66B | -2.60% | 267,472 | 612.84M |
| 105 | AXSM | Axsome Therapeutics, Inc. | 10.63B | -1.17% | 169,185 | 776.57M |
| 106 | IONS | Ionis Pharmaceuticals, Inc. | 10.60B | 2.85% | 1,227,959 | 874.09M |
| 107 | KYMR | Kymera Therapeutics, Inc. | 10.59B | 5.25% | 441,309 | 105.00M |
| 108 | SMMT | Summit Therapeutics Inc. | 10.59B | 4.24% | 3,917,426 | - |
| 109 | KRYS | Krystal Biotech, Inc. | 10.54B | 4.18% | 88,107 | 440.48M |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.40B | 1.87% | 135,862 | 2.59B |
| 111 | RDY | Dr. Reddy's Laboratories Limited | 10.36B | 1.06% | 924,098 | 3.50B |
| 112 | MOH | Molina Healthcare, Inc. | 10.36B | 0.20% | 239,183 | 42.47B |
| 113 | UHS | Universal Health Services, Inc. | 10.35B | -0.48% | 158,134 | 18.11B |
| 114 | ENSG | The Ensign Group, Inc. | 10.34B | -0.21% | 113,022 | 5.49B |
| 115 | RGEN | Repligen Corporation | 10.27B | 0.17% | 402,131 | 785.10M |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 10.21B | -0.64% | 193,272 | 7.46M |
| 117 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.04% | 324,712 | - |
| 118 | HSIC | Henry Schein, Inc. | 9.97B | -0.01% | 307,983 | 13.60B |
| 119 | PODD | Insulet Corporation | 9.94B | -1.42% | 1,009,051 | 3.05B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.89B | -1.24% | 267,476 | 281.99M |
| 121 | AVTR | Avantor, Inc. | 9.77B | 1.26% | 2,418,527 | 6.56B |
| 122 | TWST | Twist Bioscience Corporation | 9.60B | 8.69% | 1,007,399 | 431.80M |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.50B | 0.99% | 255,942 | - |
| 124 | OSCR | Oscar Health, Inc. | 9.41B | -4.06% | 1,986,804 | 15.32B |
| 125 | PCVX | Vaxcyte, Inc. | 9.25B | 0.47% | 498,967 | - |
| 126 | IMVT | Immunovant, Inc. | 9.02B | 0.76% | 335,548 | - |
| 127 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | 0.05% | 877,439 | 42.16M |
| 128 | QGEN | Qiagen N.V. | 8.95B | 3.57% | 1,449,267 | 2.10B |
| 129 | BRKR | Bruker Corporation | 8.83B | 1.67% | 616,887 | 3.50B |
| 130 | HQY | HealthEquity, Inc. | 8.74B | -0.84% | 277,297 | 1.34B |
| 131 | ATR | AptarGroup, Inc. | 8.53B | -0.48% | 84,661 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.48B | 2.07% | 2,285,851 | 616.91M |
| 133 | IBRX | ImmunityBio, Inc. | 8.45B | 5.15% | 5,527,003 | 165.79M |
| 134 | ALKS | Alkermes plc | 8.27B | 0.82% | 273,599 | 1.67B |
| 135 | TGTX | TG Therapeutics, Inc. | 7.90B | -0.61% | 1,065,832 | 799.54M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.84B | 6.12% | 2,857,013 | 989.61M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.76B | 1.15% | 143,193 | 239.92M |
| 138 | HIMS | Hims & Hers Health, Inc. | 7.45B | 2.67% | 6,232,770 | 2.58B |
| 139 | HNGE | Hinge Health, Inc. | 7.22B | -0.56% | 1,105,319 | 720.06M |
| 140 | SRRK | Scholar Rock Holding Corporation | 7.17B | 1.20% | 659,170 | - |
| 141 | CHE | Chemed Corporation | 7.06B | 0.23% | 84,751 | 2.60B |
| 142 | CGON | CG Oncology, Inc. | 7.02B | 1.29% | 279,903 | 6.23M |
| 143 | GRFS | Grifols, S.A. | 6.94B | 0.63% | 220,470 | 8.48B |
| 144 | PACS | PACS Group, Inc. | 6.89B | -1.60% | 216,961 | 5.55B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.74B | -0.59% | 327,524 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.60B | 0.24% | 488,126 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.57B | 2.62% | 32,456 | - |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.40B | 1.87% | 147,265 | 618.07M |
| 149 | LQDA | Liquidia Corporation | 6.38B | 1.36% | 361,960 | 450.91M |
| 150 | COGT | Cogent Biosciences, Inc. | 6.38B | 1.38% | 389,787 | - |
| 151 | STVN | Stevanato Group S.p.A. | 6.28B | 3.19% | 80,048 | 1.40B |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 6.27B | 1.87% | 300,474 | 1.90M |
| 153 | TVTX | Travere Therapeutics, Inc. | 6.26B | 1.75% | 433,677 | 591.33M |
| 154 | ERAS | Erasca, Inc. | 6.24B | 1.42% | 1,356,105 | - |
| 155 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.24B | 0.74% | 235,752 | 840.85M |
| 156 | BLCO | Bausch + Lomb Corporation | 6.14B | -0.72% | 265,959 | 5.32B |
| 157 | PTCT | PTC Therapeutics, Inc. | 6.08B | 2.50% | 257,197 | 1.01B |
| 158 | RDNT | RadNet, Inc. | 6.00B | 2.12% | 157,936 | 2.27B |
| 159 | DFTX | Definium Therapeutics, Inc. | 6.00B | 3.19% | 699,594 | - |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.90B | 0.58% | 136,332 | 7.50M |
| 161 | CRSP | CRISPR Therapeutics AG | 5.89B | 6.70% | 1,277,543 | 13.39M |
| 162 | TFX | Teleflex Incorporated | 5.88B | 0.36% | 148,813 | 2.25B |
| 163 | AMRX | Amneal Pharmaceuticals, Inc. | 5.66B | -0.34% | 393,441 | 3.12B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.62B | 0.66% | 112,351 | 290.54M |
| 165 | SHC | Sotera Health Company | 5.55B | 1.51% | 702,077 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.46B | 1.22% | 338,906 | 1.58B |
| 167 | MMED | MiniMed Group, Inc. | 5.37B | -4.06% | 453,336 | 3.10B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.29B | 3.49% | 707,992 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.93B | 0.02% | 174,564 | 1.35B |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.92B | 1.42% | 697,541 | - |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.88B | 0.49% | 630,911 | - |
| 172 | PBLS | Parabilis Medicines, Inc. | 4.85B | 2.11% | 174,191 | 148.00K |
| 173 | WAY | Waystar Holding Corp. | 4.85B | -0.32% | 654,232 | 1.21B |
| 174 | BLLN | BillionToOne, Inc. | 4.72B | 3.47% | 520,900 | 397.41M |
| 175 | LFST | LifeStance Health Group, Inc. | 4.60B | -1.07% | 1,044,943 | 1.58B |
| 176 | CELC | Celcuity Inc. | 4.56B | 2.57% | 279,925 | - |
| 177 | ICUI | ICU Medical, Inc. | 4.55B | -0.36% | 33,396 | 2.16B |
| 178 | RLAY | Relay Therapeutics, Inc. | 4.53B | 4.61% | 1,139,617 | 10.35M |
| 179 | ELVN | Enliven Therapeutics, Inc. | 4.49B | 0.28% | 268,656 | - |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.44B | -0.54% | 239,759 | 2.29B |
| 181 | DOCS | Doximity, Inc. | 4.43B | -1.82% | 741,578 | 655.57M |
| 182 | HTFL | HeartFlow, Inc. | 4.41B | 1.14% | 914,679 | 212.07M |
| 183 | NVST | Envista Holdings Corporation | 4.40B | 0.18% | 1,454,570 | 2.86B |
| 184 | LIVN | LivaNova PLC | 4.35B | 0.96% | 250,761 | 1.47B |
| 185 | MANE | Veradermics, Incorporated | 4.29B | 4.32% | 405,055 | - |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.26B | -0.26% | 836,582 | 1.33B |
| 187 | ITGR | Integer Holdings Corporation | 4.26B | 0.14% | 381,391 | 1.84B |
| 188 | ADPT | Adaptive Biotechnologies Corporation | 4.18B | 2.62% | 550,139 | 308.08M |
| 189 | LEGN | Legend Biotech Corporation | 4.17B | 2.87% | 705,364 | 1.27B |
| 190 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.16B | -2.10% | 1,240,401 | -665.00K |
| 191 | TNGX | Tango Therapeutics, Inc. | 4.13B | -0.12% | 1,165,151 | 53.81M |
| 192 | IRTC | iRhythm Holdings, Inc. | 4.12B | -0.32% | 182,653 | 825.34M |
| 193 | IDYA | IDEAYA Biosciences, Inc. | 4.11B | 6.37% | 531,189 | 234.13M |
| 194 | DNLI | Denali Therapeutics Inc. | 4.01B | 3.76% | 516,470 | 3.60M |
| 195 | VKTX | Viking Therapeutics, Inc. | 4.01B | 3.39% | 1,267,399 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.97B | 3.55% | 258,893 | 117.00M |
| 197 | ABCL | AbCellera Biologics Inc. | 3.95B | 14.99% | 7,714,792 | 66.17M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.93B | -0.09% | 71,714 | 890.79M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.78B | 3.60% | 6,020,573 | 324.97M |
| 200 | GRAL | GRAIL, Inc. | 3.64B | 6.45% | 313,977 | 165.26M |
| 201 | OGN | Organon & Co. | 3.61B | -0.04% | 1,763,390 | 6.13B |
| 202 | GPCR | Structure Therapeutics Inc. | 3.54B | 1.22% | 246,345 | - |
| 203 | NHC | National HealthCare Corporation | 3.53B | -1.29% | 63,412 | 1.56B |
| 204 | QURE | uniQure N.V. | 3.52B | 6.87% | 1,306,937 | 18.67M |
| 205 | PLSE | Pulse Biosciences, Inc. | 3.49B | -0.45% | 187,673 | 1.19M |
| 206 | VCYT | Veracyte, Inc. | 3.49B | 4.59% | 461,037 | 561.90M |
| 207 | OPCH | Option Care Health, Inc. | 3.48B | -1.82% | 1,435,911 | 5.69B |
| 208 | IMNM | Immunome, Inc. | 3.35B | 5.43% | 660,196 | 4.02M |
| 209 | MBX | MBX Biosciences, Inc. | 3.33B | 4.13% | 124,481 | - |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 3.28B | 2.16% | 1,283,178 | 7.12M |
| 211 | CLDX | Celldex Therapeutics, Inc. | 3.25B | 2.14% | 258,697 | 158.00K |
| 212 | TMDX | TransMedics Group, Inc. | 3.24B | -0.17% | 197,988 | 668.47M |
| 213 | WRBY | Warby Parker Inc. | 3.22B | -0.53% | 769,995 | 911.61M |
| 214 | IRON | Disc Medicine, Inc. | 3.17B | 2.07% | 132,432 | - |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 3.17B | -0.76% | 236,993 | 606.33M |
| 216 | BEAM | Beam Therapeutics Inc. | 3.14B | 10.84% | 1,007,239 | 156.04M |
| 217 | ARQT | Arcutis Biotherapeutics, Inc. | 3.14B | 0.73% | 435,682 | 463.98M |
| 218 | ALMS | Alumis Inc. | 3.06B | 2.63% | 236,471 | 7.40M |
| 219 | ZLAB | Zai Lab Limited | 2.97B | 3.04% | 355,356 | 449.61M |
| 220 | AVAH | Aveanna Healthcare Holdings Inc. | 2.96B | -1.09% | 1,490,770 | 2.60B |
| 221 | BKD | Brookdale Senior Living Inc. | 2.92B | 0.83% | 1,964,045 | 2.93B |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 2.89B | -0.24% | 5,711,042 | - |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.81B | 2.93% | 339,873 | 36.77M |
| 224 | VRDN | Viridian Therapeutics, Inc. | 2.79B | 2.62% | 410,217 | 71.13M |
| 225 | ALHC | Alignment Healthcare, Inc. | 2.77B | -0.74% | 1,871,482 | 4.58B |
| 226 | ATAI | AtaiBeckley Inc. | 2.75B | 0.47% | 8,228,203 | 4.47M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.73B | 2.16% | 500,319 | 3.37B |
| 228 | RGC | Regencell Bioscience Holdings Limited | 2.69B | 2.74% | 49,882 | - |
| 229 | PRVA | Privia Health Group, Inc. | 2.67B | -0.62% | 603,824 | 2.36B |
| 230 | AXGN | Axogen, Inc. | 2.66B | 0.55% | 230,848 | 251.17M |
| 231 | PGEN | Precigen, Inc. | 2.65B | 3.21% | 3,004,955 | 85.72M |
| 232 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | 4.24% | 2,322,830 | 717.00M |
| 233 | SUPN | Supernus Pharmaceuticals, Inc. | 2.63B | 0.24% | 305,659 | 830.44M |
| 234 | WGS | GeneDx Holdings Corp. | 2.61B | 2.74% | 399,350 | 454.43M |
| 235 | PHVS | Pharvaris N.V. | 2.60B | -0.80% | 697,108 | - |
| 236 | CDNA | CareDx, Inc. | 2.58B | 4.82% | 1,006,961 | 458.09M |
| 237 | GENB | Generate Biomedicines, Inc. | 2.57B | 12.92% | 3,579,158 | 26.48M |
| 238 | TRVI | Trevi Therapeutics, Inc. | 2.56B | -0.66% | 611,045 | - |
| 239 | NKTR | Nektar Therapeutics | 2.54B | 0.98% | 233,022 | 54.59M |
| 240 | NEOG | Neogen Corporation | 2.54B | 0.26% | 326,982 | 870.40M |
| 241 | VERA | Vera Therapeutics, Inc. | 2.53B | 4.30% | 1,533,124 | - |
| 242 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.52B | 1.70% | 1,003,761 | 940.61M |
| 243 | ATRC | AtriCure, Inc. | 2.48B | -0.95% | 477,159 | 569.62M |
| 244 | KOD | Kodiak Sciences Inc. | 2.47B | 5.92% | 315,089 | - |
| 245 | NUVB | Nuvation Bio Inc. | 2.45B | 3.33% | 1,851,580 | 169.90M |
| 246 | BHC | Bausch Health Companies Inc. | 2.45B | -2.02% | 1,790,870 | 10.85B |
| 247 | PBH | Prestige Consumer Healthcare Inc. | 2.44B | -1.15% | 159,431 | 1.10B |
| 248 | RAPP | Rapport Therapeutics, Inc. | 2.43B | 2.76% | 175,419 | 20.00M |
| 249 | BFLY | Butterfly Network, Inc. | 2.43B | 1.90% | 2,762,585 | 112.14M |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.42B | 2.13% | 839,195 | 52.06M |
| 251 | UFPT | UFP Technologies, Inc. | 2.37B | 0.07% | 64,668 | 631.64M |
| 252 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | 5.28% | 469,926 | - |
| 253 | GRDN | Guardian Pharmacy Services, Inc. | 2.34B | -2.08% | 199,330 | 1.46B |
| 254 | ALMR | Alamar Biosciences, Inc. | 2.33B | 2.60% | 156,737 | 100.42M |
| 255 | KLRA | Kailera Therapeutics, Inc. | 2.31B | 7.62% | 806,965 | - |
| 256 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.30B | 4.92% | 3,086,133 | 208.78M |
| 257 | COAG | Hemab Therapeutics Holdings, Inc. | 2.29B | 5.21% | 250,602 | - |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 0.70% | 158,286 | 959.90M |
| 259 | URGN | UroGen Pharma Ltd. | 2.26B | 0.03% | 213,842 | 188.73M |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.21% | 373,914 | 311.51M |
| 261 | VCEL | Vericel Corporation | 2.21B | 1.82% | 219,271 | 306.30M |
| 262 | ADUS | Addus HomeCare Corporation | 2.20B | -0.24% | 76,728 | 1.48B |
| 263 | BHVN | Biohaven Ltd. | 2.20B | 6.51% | 1,559,825 | - |
| 264 | XNCR | Xencor, Inc. | 2.19B | 1.64% | 635,515 | 104.97M |
| 265 | MESO | Mesoblast Limited | 2.19B | 3.37% | 101,711 | 65.38M |
| 266 | ADMA | ADMA Biologics, Inc. | 2.18B | 2.09% | 550,960 | 512.28M |
| 267 | TRLV | Trulieve Cannabis Corp. | 2.18B | 1.44% | 1,011,793 | 1.14B |
| 268 | ESTA | Establishment Labs Holdings Inc. | 2.16B | 0.57% | 134,817 | 245.82M |
| 269 | STOK | Stoke Therapeutics, Inc. | 2.16B | 3.43% | 348,273 | 27.59M |
| 270 | NEO | NeoGenomics, Inc. | 2.16B | 2.25% | 373,828 | 766.30M |
| 271 | XRAY | DENTSPLY SIRONA Inc. | 2.15B | -0.87% | 1,398,394 | 3.64B |
| 272 | CLOV | Clover Health Investments, Corp. | 2.15B | -1.46% | 1,532,871 | 2.48B |
| 273 | ZBIO | Zenas BioPharma, Inc. | 2.14B | 3.92% | 274,268 | 1.00M |
| 274 | PVLA | Palvella Therapeutics, Inc. | 2.13B | 1.56% | 111,116 | - |
| 275 | MD | Pediatrix Medical Group, Inc. | 2.12B | 0.71% | 214,908 | 1.95B |
| 276 | HCM | HUTCHMED (China) Limited | 2.11B | 0.78% | 45,069 | 549.12M |
| 277 | CMPS | COMPASS Pathways plc | 2.05B | 4.51% | 1,565,890 | - |
| 278 | NVCR | NovoCure Limited | 2.05B | 4.83% | 345,024 | 699.19M |
| 279 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | 4.61% | 625,429 | 5.49M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 3.89% | 332,666 | 98.34M |
| 281 | NBTX | Nanobiotix S.A. | 2.02B | 4.89% | 150,583 | 38.27M |
| 282 | PRGO | Perrigo Company plc | 2.01B | 1.26% | 1,794,036 | 4.14B |
| 283 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | 4.36% | 660,224 | 1.97B |
| 284 | GHRS | GH Research PLC | 1.98B | 2.58% | 51,006 | - |
| 285 | PGNY | Progyny, Inc. | 1.97B | 0.98% | 437,240 | 1.31B |
| 286 | KARD | Kardigan, Inc. | 1.96B | 1.36% | 144,466 | - |
| 287 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.01% | 1,063,046 | - |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.92B | 2.93% | 180,070 | 481.07M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.91B | 8.76% | 2,436,866 | 59.51M |
| 290 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | 9.69% | 13,588,035 | 54.86M |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.91B | 2.14% | 90,203 | - |
| 292 | IMCR | Immunocore Holdings plc | 1.91B | 1.30% | 101,152 | 430.78M |
| 293 | SEPN | Septerna, Inc. | 1.91B | 0.78% | 87,708 | 98.88M |
| 294 | ASTH | Astrana Health, Inc. | 1.90B | -2.44% | 152,662 | 3.84B |
| 295 | ZYME | Zymeworks Inc. | 1.89B | -7.54% | 1,466,333 | 37.13M |
| 296 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 2.19% | 223,511 | 1.13B |
| 297 | ALVO | Alvotech | 1.86B | -0.95% | 1,357,625 | 494.61M |
| 298 | PSNL | Personalis, Inc. | 1.85B | 1.47% | 1,735,653 | 69.67M |
| 299 | VIR | Vir Biotechnology, Inc. | 1.84B | 9.59% | 1,862,115 | 303.23M |
| 300 | LMAT | LeMaitre Vascular, Inc. | 1.82B | -0.26% | 186,359 | 262.43M |
| 301 | BLFS | BioLife Solutions, Inc. | 1.82B | 0.05% | 459,094 | 106.69M |
| 302 | SGRY | Surgery Partners, Inc. | 1.81B | 0.07% | 628,431 | 3.37B |
| 303 | BRVE | Braveheart Bio, Inc. | 1.81B | 2.55% | 71,166 | - |
| 304 | ETON | Eton Pharmaceuticals, Inc. | 1.81B | -1.96% | 278,332 | 105.60M |
| 305 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | 2.86% | 446,128 | 252.25M |
| 306 | INBX | Inhibrx Biosciences, Inc. | 1.77B | 14.83% | 321,976 | 1.30M |
| 307 | INSP | Inspire Medical Systems, Inc. | 1.77B | -0.49% | 127,445 | 898.74M |
| 308 | FTRE | Fortrea Holdings Inc. | 1.73B | -0.44% | 300,765 | 2.68B |
| 309 | ANAB | AnaptysBio, Inc. | 1.71B | -1.04% | 170,329 | 232.39M |
| 310 | AVLN | Avalyn Pharma Inc. | 1.71B | 2.28% | 61,244 | - |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.69B | 2.80% | 197,731 | 20.00M |
| 312 | ABSI | Absci Corporation | 1.66B | 9.50% | 1,477,530 | 1.56M |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.64B | 5.26% | 191,518 | - |
| 314 | TRAX | First Tracks Biotherapeutics, Inc. | 1.62B | 5.04% | 199,447 | - |
| 315 | ANIP | ANI Pharmaceuticals, Inc. | 1.61B | 1.32% | 380,155 | 978.38M |
| 316 | TYRA | Tyra Biosciences, Inc. | 1.60B | 2.72% | 116,214 | - |
| 317 | AGL | agilon health, inc. | 1.59B | 1.22% | 97,935 | 5.92B |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | -0.11% | 467,737 | 335.41M |
| 319 | LBRX | LB Pharmaceuticals Inc | 1.58B | 1.58% | 130,821 | - |
| 320 | ARDT | Ardent Health, Inc. | 1.58B | -0.53% | 172,978 | 6.41B |
| 321 | KMTS | Kestra Medical Technologies, Ltd. | 1.57B | -0.74% | 71,219 | 95.13M |
| 322 | AAPG | Ascentage Pharma Group International | 1.56B | 1.32% | 1,356 | 94.61M |
| 323 | HROW | Harrow, Inc. | 1.56B | 4.52% | 248,885 | 275.59M |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.56B | -0.48% | 95,523 | 1.86B |
| 325 | NVAX | Novavax, Inc. | 1.55B | 6.32% | 4,733,771 | 413.80M |
| 326 | CNMD | CONMED Corporation | 1.53B | -0.72% | 70,895 | 1.37B |
| 327 | OMCL | Omnicell, Inc. | 1.53B | -3.23% | 283,006 | 1.25B |
| 328 | INVA | Innoviva, Inc. | 1.52B | 0.29% | 153,887 | 440.00M |
| 329 | SLBT | SL Science Holding Limited | 1.52B | -1.48% | 56,945 | 3.27M |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.52B | 9.24% | 484,623 | - |
| 331 | TNDM | Tandem Diabetes Care, Inc. | 1.51B | -2.34% | 569,106 | 1.04B |
| 332 | FRNM | Freenome, Inc. | 1.50B | 1.52% | 303,394 | 35.41M |
| 333 | APMD | Apnimed, Inc. | 1.50B | 5.74% | 360,459 | 120.15M |
| 334 | REPL | Replimune Group, Inc. | 1.49B | 7.82% | 2,245,544 | - |
| 335 | SDGR | Schrödinger, Inc. | 1.48B | 5.65% | 524,297 | 259.04M |
| 336 | CGEM | Cullinan Therapeutics, Inc. | 1.48B | 5.50% | 228,811 | - |
| 337 | INNV | InnovAge Holding Corp. | 1.48B | -1.09% | 40,368 | 949.17M |
| 338 | OMDA | Omada Health, Inc. | 1.48B | 0.17% | 328,165 | 309.76M |
| 339 | ENOV | Enovis Corporation | 1.47B | 1.01% | 182,806 | 2.30B |
| 340 | AZTA | Azenta, Inc. | 1.46B | 1.06% | 404,090 | 613.81M |
| 341 | AKTS | Aktis Oncology, Inc. | 1.45B | 0.23% | 389,791 | 10.06M |
| 342 | ORIC | ORIC Pharmaceuticals, Inc. | 1.45B | 3.79% | 530,694 | - |
| 343 | PAHC | Phibro Animal Health Corporation | 1.44B | 0.82% | 101,102 | 1.50B |
| 344 | ATEC | Alphatec Holdings, Inc. | 1.44B | 0.65% | 707,502 | 815.05M |
| 345 | LTGO | Latigo Biotherapeutics, Inc. | 1.44B | 3.18% | 24,312 | - |
| 346 | VOR | Vor Biopharma Inc. | 1.43B | 6.52% | 822,772 | - |
| 347 | SVRA | Savara Inc. | 1.43B | 1.26% | 1,089,049 | - |
| 348 | ANRO | Alto Neuroscience, Inc. | 1.43B | 0.44% | 283,936 | - |
| 349 | MGTX | MeiraGTx Holdings plc | 1.42B | -0.20% | 345,359 | 397.50M |
| 350 | OMER | Omeros Corporation | 1.40B | 0.10% | 669,112 | 38.42M |
| 351 | JBIO | Jade Biosciences, Inc. | 1.37B | 0.98% | 308,497 | - |
| 352 | MLTX | MoonLake Immunotherapeutics | 1.35B | 3.38% | 442,668 | - |
| 353 | MNKD | MannKind Corporation | 1.35B | 3.19% | 912,365 | 393.63M |
| 354 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -1.16% | 344,857 | - |
| 355 | PNTG | The Pennant Group, Inc. | 1.32B | -2.55% | 111,463 | 1.10B |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.32B | 2.45% | 40,207 | - |
| 357 | AMN | AMN Healthcare Services, Inc. | 1.31B | -2.04% | 192,771 | 3.43B |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.30B | 0.48% | 122,807 | 1.65B |
| 359 | AORT | Artivion, Inc. | 1.29B | -1.67% | 253,988 | 471.47M |
| 360 | NUTX | Nutex Health Inc. | 1.27B | -1.25% | 128,013 | 846.72M |
| 361 | CRON | Cronos Group Inc. | 1.26B | 2.49% | 1,861,470 | 179.09M |
| 362 | IMTX | Immatics N.V. | 1.25B | 5.18% | 619,633 | 47.65M |
| 363 | ODTX | Odyssey Therapeutics, Inc. | 1.25B | 3.54% | 66,413 | 99.00K |
| 364 | CERT | Certara, Inc. | 1.25B | 2.64% | 723,608 | 421.75M |
| 365 | GLUE | Monte Rosa Therapeutics, Inc. | 1.24B | 5.48% | 558,490 | 28.73M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 4.47% | 213,741 | - |
| 367 | SANA | Sana Biotechnology, Inc. | 1.23B | 8.73% | 1,702,503 | - |
| 368 | PRCT | PROCEPT BioRobotics Corporation | 1.23B | 1.08% | 244,339 | 337.34M |
| 369 | KURA | Kura Oncology, Inc. | 1.21B | 10.00% | 3,694,044 | 77.23M |
| 370 | GDRX | GoodRx Holdings, Inc. | 1.18B | 0.44% | 422,289 | 785.23M |
| 371 | BVS | Bioventus Inc. | 1.18B | -0.14% | 262,154 | 581.85M |
| 372 | STAA | STAAR Surgical Company | 1.18B | 0.77% | 267,798 | 339.59M |
| 373 | USPH | U.S. Physical Therapy, Inc. | 1.16B | 0.14% | 73,318 | 804.27M |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | 1.01% | 147,682 | 1.04B |
| 375 | JANX | Janux Therapeutics, Inc. | 1.15B | 1.13% | 529,816 | 24.00M |
| 376 | IRMD | IRADIMED CORPORATION | 1.14B | 1.93% | 49,543 | 86.34M |
| 377 | TDOC | Teladoc Health, Inc. | 1.13B | - | 1,530,473 | 2.49B |
| 378 | OPK | OPKO Health, Inc. | 1.12B | 1.69% | 1,134,499 | 587.90M |
| 379 | IVA | Inventiva S.A. | 1.09B | 1.81% | 227,791 | 7.94M |
| 380 | IMMX | Immix Biopharma, Inc. | 1.06B | 9.26% | 2,773,561 | - |
| 381 | CSTL | Castle Biosciences, Inc. | 1.06B | 3.82% | 148,587 | 357.28M |
| 382 | CADL | Candel Therapeutics, Inc. | 1.05B | 7.12% | 799,815 | - |
| 383 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 1.82% | 452,430 | 59.00K |
| 384 | SLDB | Solid Biosciences Inc. | 1.05B | 6.88% | 574,784 | - |
| 385 | WVE | Wave Life Sciences, Inc. | 1.05B | 3.71% | 1,211,664 | 65.37M |
| 386 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.22% | 1,040,118 | 41.47M |
| 387 | ABUS | Arbutus Biopharma Corporation | 1.03B | -0.10% | 5,131,314 | 181.72M |
| 388 | CLYM | Climb Bio, Inc. | 1.03B | 9.09% | 761,762 | - |
| 389 | QDEL | QuidelOrtho Corporation | 1.03B | 3.38% | 327,759 | 2.67B |
| 390 | HELP | Cybin Inc. | 1.02B | 7.07% | 2,227,061 | - |
| 391 | PCRX | Pacira BioSciences, Inc. | 1.00B | 1.33% | 97,756 | 746.16M |
| 392 | GMRS | GMR Solutions Inc. | 998.72M | -2.95% | 163,005 | 5.88B |
| 393 | GERN | Geron Corporation | 986.20M | 0.99% | 4,659,156 | 204.56M |
| 394 | DSGN | Design Therapeutics, Inc. | 978.15M | 2.63% | 405,084 | - |
| 395 | ANNX | Annexon, Inc. | 976.33M | 1.78% | 951,054 | - |
| 396 | ACRS | Aclaris Therapeutics, Inc. | 968.57M | 4.28% | 2,596,105 | 8.22M |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 962.47M | 5.47% | 376,881 | - |
| 398 | ARDX | Ardelyx, Inc. | 961.86M | 3.21% | 1,560,409 | 450.89M |
| 399 | GLAS | Glass House Brands Inc. | 951.85M | 2.23% | 219,188 | 176.98M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 923.07M | 0.84% | 90,192 | 730.02M |
| 401 | CBLL | CeriBell, Inc. | 912.25M | -0.71% | 127,532 | 101.96M |
| 402 | COLL | Collegium Pharmaceutical, Inc. | 897.88M | 0.84% | 289,022 | 808.21M |
| 403 | FTH | Faeth Therapeutics, Inc. | 890.20M | -0.75% | 178,574 | - |
| 404 | ANL | Adlai Nortye Ltd. | 887.40M | -2.68% | 56,975 | 18.06M |
| 405 | SGP | SpyGlass Pharma, Inc. | 883.36M | 0.57% | 31,693 | - |
| 406 | TBPH | Theravance Biopharma, Inc. | 882.88M | -0.03% | 90,199 | 104.31M |
| 407 | SIBN | SI-BONE, Inc. | 878.89M | 0.72% | 156,363 | 213.60M |
| 408 | RIGL | Rigel Pharmaceuticals, Inc. | 876.65M | 4.03% | 133,811 | 276.79M |
| 409 | DBVT | DBV Technologies S.A. | 873.69M | 5.52% | 98,849 | 5.04M |
| 410 | FDMT | 4D Molecular Therapeutics, Inc. | 870.65M | 2.40% | 433,357 | 92.01M |
| 411 | INMD | InMode Ltd. | 864.51M | -0.40% | 161,402 | 374.63M |
| 412 | ATTO | Attovia Therapeutics, Inc. | 864.02M | -2.62% | 59,586 | 1.35M |
| 413 | AVR | Anteris Technologies Global Corp. | 862.51M | 0.57% | 141,049 | 2.24M |
| 414 | AHG | Akso Health Group | 847.88M | 4.95% | 4,821 | 13.83M |
| 415 | BBNX | Beta Bionics, Inc. | 845.36M | -4.76% | 353,417 | 119.01M |
| 416 | ACHV | Achieve Life Sciences, Inc. | 844.83M | 3.40% | 745,551 | - |
| 417 | HSTM | HealthStream, Inc. | 842.99M | 0.17% | 38,216 | 321.12M |
| 418 | PHAR | Pharming Group N.V. | 830.52M | 3.32% | 18,571 | 366.48M |
| 419 | NGNE | Neurogene Inc. | 828.87M | 4.49% | 432,743 | 925.00K |
| 420 | OBX | Obsidian Therapeutics, Inc. | 825.37M | 1.87% | 105,247 | - |
| 421 | SLN | Silence Therapeutics plc | 824.87M | 3.09% | 368,332 | 615.00K |
| 422 | AURA | Aura Biosciences, Inc. | 821.34M | 0.25% | 863,837 | - |
| 423 | OCS | Oculis Holding AG | 814.86M | 0.15% | 145,069 | 1.45M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 804.11M | 3.39% | 86,721 | - |
| 425 | STTK | Shattuck Labs, Inc. | 798.89M | 0.76% | 457,479 | 1.00M |
| 426 | VREX | Varex Imaging Corporation | 780.16M | -0.05% | 300,311 | 865.00M |
| 427 | DRUG | Bright Minds Biosciences Inc. | 768.91M | 3.28% | 121,252 | - |
| 428 | ALLO | Allogene Therapeutics, Inc. | 754.90M | 7.64% | 3,697,698 | 4.64M |
| 429 | SOPH | SOPHiA GENETICS SA | 745.72M | 3.67% | 608,913 | 86.17M |
| 430 | AHCO | AdaptHealth Corp. | 743.09M | -1.07% | 999,605 | 3.36B |
| 431 | CBIO | Crescent Biopharma, Inc. | 740.46M | 1.94% | 72,848 | 11.88M |
| 432 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 739.61M | 0.93% | 67,257 | - |
| 433 | TECX | Tectonic Therapeutic, Inc. | 737.40M | 3.43% | 86,158 | - |
| 434 | MNPR | Monopar Therapeutics Inc. | 737.33M | -1.36% | 62,176 | - |
| 435 | CTMX | CytomX Therapeutics, Inc. | 736.50M | 2.74% | 1,820,857 | 18.30M |
| 436 | ASMB | Assembly Biosciences, Inc. | 735.42M | 2.38% | 252,587 | 74.85M |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 719.62M | 5.45% | 1,131,828 | 389.32M |
| 438 | ZVRA | Zevra Therapeutics, Inc. | 715.57M | 3.43% | 402,833 | 136.07M |
| 439 | PHR | Phreesia, Inc. | 712.38M | -1.41% | 269,260 | 495.59M |
| 440 | SSII | SS Innovations International, Inc. | 705.36M | 0.57% | 27,276 | 52.40M |
| 441 | GYRE | Gyre Therapeutics, Inc. | 703.00M | 2.95% | 30,364 | 109.82M |
| 442 | PHAT | Phathom Pharmaceuticals, Inc. | 696.60M | 1.27% | 261,948 | 239.66M |
| 443 | AGMB | AgomAb Therapeutics NV | 695.63M | 10.18% | 186,108 | - |
| 444 | MPLT | MapLight Therapeutics, Inc. | 695.25M | 10.12% | 245,329 | - |
| 445 | OABI | OmniAb, Inc. | 684.79M | - | 763,291 | 38.46M |
| 446 | EVO | Evotec SE | 674.99M | - | 17,974 | 819.47M |
| 447 | PRLD | Prelude Therapeutics Incorporated | 674.62M | 1.24% | 237,917 | 22.42M |
| 448 | EIKN | Eikon Therapeutics, Inc. | 672.19M | 11.20% | 327,603 | - |
| 449 | CRMD | CorMedix Inc. | 658.63M | 2.05% | 512,275 | 462.25M |
| 450 | CTNM | Contineum Therapeutics, Inc. | 658.37M | 5.23% | 491,210 | - |
| 451 | ANGO | AngioDynamics, Inc. | 655.53M | 0.57% | 58,452 | 320.17M |
| 452 | PRME | Prime Medicine, Inc. | 649.35M | 12.31% | 2,037,368 | 4.07M |
| 453 | TLRY | Tilray Brands, Inc. | 646.88M | 1.06% | 1,909,436 | 915.45M |
| 454 | VSTM | Verastem, Inc. | 646.62M | 4.08% | 588,793 | 87.53M |
| 455 | KIDS | OrthoPediatrics Corp. | 644.39M | -1.56% | 98,919 | 252.72M |
| 456 | SGMT | Sagimet Biosciences Inc. | 642.10M | 1.18% | 463,518 | - |
| 457 | AUTL | Autolus Therapeutics plc | 636.13M | 2.14% | 873,096 | 117.39M |
| 458 | VALN | Valneva SE | 635.77M | -0.32% | 17,496 | 163.30M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 634.46M | 5.31% | 2,634,116 | 54.09M |
| 460 | MDXG | MiMedx Group, Inc. | 633.33M | 1.76% | 258,001 | 355.17M |
| 461 | CTEV | Claritev Corporation | 633.33M | 2.16% | 62,577 | 994.67M |
| 462 | SCTX | Scribe Therapeutics Inc. | 632.52M | -9.99% | 209,456 | 36.28M |
| 463 | STLN | Starling Oncology, Inc. | 631.88M | 1.14% | 691,207 | 587.24M |
| 464 | ARVN | Arvinas, Inc. | 630.32M | 3.21% | 252,085 | 316.70M |
| 465 | ZURA | Zura Bio Limited | 617.14M | 2.22% | 2,104,214 | - |
| 466 | ALT | Altimmune, Inc. | 614.68M | 1.61% | 1,654,959 | 31.00K |
| 467 | ENTX | Entera Bio Ltd. | 607.73M | 2.63% | 280,292 | 42.00K |
| 468 | EOLS | Evolus, Inc. | 599.08M | 3.30% | 1,197,322 | 316.49M |
| 469 | DCTH | Delcath Systems, Inc. | 592.31M | 1.91% | 237,428 | 95.42M |
| 470 | RGNX | REGENXBIO Inc. | 588.84M | 10.74% | 1,139,479 | 174.48M |
| 471 | CTKB | Cytek Biosciences, Inc. | 588.82M | 2.03% | 270,964 | 206.71M |
| 472 | WEAV | Weave Communications, Inc. | 583.59M | 0.07% | 2,892,983 | 257.79M |
| 473 | BWAY | BrainsWay Ltd. | 580.32M | 1.54% | 26,500 | 60.70M |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 574.95M | 2.08% | 123,934 | 251.00K |
| 475 | OVID | Ovid Therapeutics Inc. | 566.36M | 2.84% | 848,959 | 1.58M |
| 476 | CERS | Cerus Corporation | 556.21M | 2.60% | 382,468 | 221.55M |
| 477 | SPRY | ARS Pharmaceuticals, Inc. | 554.42M | 4.21% | 639,764 | 116.93M |
| 478 | CABA | Cabaletta Bio, Inc. | 549.33M | 4.52% | 2,216,180 | - |
| 479 | SRTA | Strata Critical Medical, Inc. | 548.94M | 3.94% | 430,900 | 255.98M |
| 480 | EVH | Evolent Health, Inc. | 546.08M | 2.33% | 1,026,863 | 2.10B |
| 481 | FLGT | Fulgent Genetics, Inc. | 545.90M | 2.01% | 82,548 | 323.93M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 543.60M | 6.67% | 450,984 | - |
| 483 | BLSM | BlossomHill Therapeutics, Inc. | 541.38M | 10.21% | 111,889 | - |
| 484 | TCMD | Tactile Systems Technology, Inc. | 535.27M | 1.16% | 211,410 | 350.31M |
| 485 | RZLT | Rezolute, Inc. | 527.56M | 0.80% | 1,192,580 | - |
| 486 | CLPT | ClearPoint Neuro, Inc. | 517.05M | 11.73% | 745,807 | 42.28M |
| 487 | PROK | ProKidney Corp. | 516.97M | 6.21% | 408,650 | 818.00K |
| 488 | CCCC | C4 Therapeutics, Inc. | 514.25M | 1.95% | 2,361,256 | 35.04M |
| 489 | SENS | Senseonics Holdings, Inc. | 510.23M | 2.88% | 276,623 | 48.55M |
| 490 | DNA | Ginkgo Bioworks Holdings, Inc. | 509.09M | 11.50% | 913,397 | 132.42M |
| 491 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 492 | EVMN | Evommune, Inc. | 500.83M | 0.95% | 209,581 | 10.00M |
| 493 | EDIT | Editas Medicine, Inc. | 500.67M | 8.67% | 2,884,484 | 47.01M |
| 494 | RLMD | Relmada Therapeutics, Inc. | 492.28M | 0.76% | 564,756 | - |
| 495 | PRTA | Prothena Corporation plc | 491.81M | 2.02% | 162,715 | 54.53M |
| 496 | KMDA | Kamada Ltd. | 489.99M | 0.83% | 51,337 | 191.85M |
| 497 | NRC | NRC Health | 485.97M | 0.23% | 23,968 | 140.00M |
| 498 | QTTB | Q32 Bio Inc. | 485.24M | -0.37% | 408,018 | 53.74M |
| 499 | NPCE | NeuroPace, Inc. | 484.66M | 0.93% | 46,078 | 106.99M |
| 500 | OCGN | Ocugen, Inc. | 479.84M | 4.04% | 1,635,691 | 4.58M |